戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 activation of ERK even when passed through a severe combined immunodeficient mouse.
2                                      A human/severe combined immunodeficient mouse chimeric model was
3  These investigations in a nonobese diabetic severe combined immunodeficient mouse-human neural cell
4  prevent progression of established CaP in a severe combined immunodeficient mouse implanted with fet
5 f normal islets in a streptozotocin-diabetic severe combined immunodeficient mouse marginal islet mas
6               The chimeric nonobese diabetic severe combined immunodeficient mouse model may be usefu
7                                            A severe combined immunodeficient mouse model of extravasa
8                                         In a severe combined immunodeficient mouse model of human NSC
9 therapy protocol for cancer were tested in a severe combined immunodeficient mouse model of human ski
10                   Finally, using a humanized severe combined immunodeficient mouse model of lymphocyt
11                             However, using a severe combined immunodeficient mouse model, in which HS
12                                         In a severe combined immunodeficient mouse model, PDGF DD exp
13  cells, using a xenogeneic nonobese diabetic/severe combined immunodeficient mouse model.
14 inant hepatic failure in a nonobese diabetic severe combined immunodeficient mouse model.
15  S.c. xenograft assays were carried out in a severe combined immunodeficient mouse model.
16  were investigated in tumors grown s.c. in a severe combined immunodeficient mouse model.
17 ithout affecting primary tumorigenicity in a severe combined immunodeficient mouse model.
18 development in a humanized nonobese diabetic-severe combined immunodeficient mouse model.
19 at our in vitro results can be extended to a severe combined immunodeficient mouse model.
20 dicates that the NOD/SCID (nonobese diabetic/severe combined immunodeficient) mouse model can be a va
21 -FC was assessed in three intracranial C.B17 severe combined immunodeficient mouse models of human gl
22 one B (dEpoB) in xenograft nonobese diabetic/severe combined immunodeficient mouse models with subcut
23 eutic treatments using both cell culture and severe combined immunodeficient mouse models.
24                           The SCID-hu mouse (severe combined immunodeficient mouse transplanted with
25         We used the SCID-hu (Thy/Liv) mouse (severe combined immunodeficient mouse transplanted with
26  10(5) organisms when blood from an infected severe combined immunodeficient mouse was used as an ino
27 tumor cells has shown promising results in a severe combined immunodeficient mouse xenograft model of
28 c. human GD2-positive melanoma growth in the severe combined immunodeficient mouse xenograft model.
29 ound to inhibit pancreatic tumor growth in a severe combined immunodeficient mouse xenograft model.
30                                              Severe combined immunodeficient mouse xenograft models o

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。